1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Does Testing More Frequently Shorten the Time to Detect Disease Progression?

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          With the rise of smartphone devices to monitor health status remotely, it is tempting to conclude that sampling more often will provide a more sensitive means of detecting changes in health status earlier over time, when interventions may improve outcomes.

          Methods

          The answer to this question is derived in the context of a model where observations are generated from a linear-trend model with independent as well as autocorrelated autoregressive-moving average, or ARMA(1,1), errors.

          Results

          The results imply a cautionary message that an increase in the sampling frequency may not always lead to a faster detection of trend changes. The benefit of rapid successive observations depends on how observations, taken closely together in time, are correlated.

          Conclusions

          Shortening the observation period by half can be accomplished by increasing the number of independent observations to maintain the same power for detecting change over time. However, a strategy to detect progression of disease sooner by taking numerous closely spaced measurements over a shortened interval is limited by the degree of autocorrelation among adjacent observations. We provide a statistical model of disease progression that allows for autocorrelation among successive measurements, and obtain the power of detecting a linear change of specified magnitude when equal-spaced observations are taken over a given time interval.

          Translational Relevance

          New emerging technology for home monitoring of visual function will provide a means to monitor sensory status more frequently. The model proposed here takes into account how successive measurements are correlated, which impacts the number of measurements needed to detect a significant change in status.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: not found

          Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study.

          To determine whether home monitoring with the ForeseeHome device (Notal Vision Ltd, Tel Aviv, Israel), using macular visual field testing with hyperacuity techniques and telemonitoring, results in earlier detection of age-related macular degeneration-associated choroidal neovascularization (CNV), reflected in better visual acuity, when compared with standard care. The main predictor of treatment outcome from anti-vascular endothelial growth factor (VEGF) agents is the visual acuity at the time of CNV treatment. Unmasked, controlled, randomized clinical trial. One thousand nine hundred and seventy participants 53 to 90 years of age at high risk of CNV developing were screened. Of these, 1520 participants with a mean age of 72.5 years were enrolled in the Home Monitoring of the Eye study at 44 Age-Related Eye Disease Study 2 clinical centers. In the standard care and device arms arm, investigator-specific instructions were provided for self-monitoring vision at home followed by report of new symptoms to the clinic. In the device arm, the device was provided with recommendations for daily testing. The device monitoring center received test results and reported changes to the clinical centers, which contacted participants for examination. The main outcome measure was the difference in best-corrected visual acuity scores between baseline and detection of CNV. The event was determined by investigators based on clinical examination, color fundus photography, fluorescein angiography, and optical coherence tomography findings. Masked graders at a central reading center evaluated the images using standardized protocols. Seven hundred sixty-three participants were randomized to device monitoring and 757 participants were randomized to standard care and were followed up for a mean of 1.4 years between July 2010 and April 2013. At the prespecified interim analysis, 82 participants progressed to CNV, 51 in the device arm and 31 in the standard care arm. The primary analysis achieved statistical significance, with the participants in the device arm demonstrating a smaller decline in visual acuity with fewer letters lost from baseline to CNV detection (median, -4 letters; interquartile range [IQR], -11.0 to -1.0 letters) compared with standard care (median, -9 letters; IQR, -14.0 to -4.0 letters; P = 0.021), resulting in better visual acuity at CNV detection in the device arm. The Data and Safety Monitoring Committee recommended early study termination for efficacy. Persons at high risk for CNV developing benefit from the home monitoring strategy for earlier detection of CNV development, which increases the likelihood of better visual acuity results after intravitreal anti-VEGF therapy. Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Intervals between visual field tests when monitoring the glaucomatous patient: wait-and-see approach.

            Published recommendations suggest three visual field (VF) tests per year are required to identify rapid progression in a newly diagnosed glaucomatous patient over 2 years. This report aims to determine if identification of progression would be improved by clustering tests at the beginning and end of the 2-year period. Computer-simulated "patients" were given a rapid VF (mean deviation [MD]) loss of -2 dB/year with added MD measurement variability. Linear regression of MD against time was used to estimate progression. One group of "patients" was measured every 6 months, another every 4 months, whereas the wait-and-see group were measured either 2 or 3 times at both baseline and at the end of a 2-year period. Stable "patients" (0 dB/year) were generated to examine the effect of the follow-up patterns on false-positive (FP) progression identification. By 2 years, 58% and 82% of rapidly progressing patients were correctly detected using evenly spaced 6- and 4-month VFs, respectively. This power of detection significantly improved to 62% and 95% with the wait-and-see approach (P < 0.001). When compared with evenly spaced VFs, the rate of MD loss was better estimated by the wait-and-see approach, but average detection time was slightly slower. Evenly spaced testing incurred a significantly higher FP rate: up to 5.9% compared with only 0.4% in wait-and-see (P < 0.001). Compared with an evenly spaced follow-up, wait-and-see identifies more "patients" with rapid VF progression with fewer FPs, making it particularly applicable to clinical trials. Modeling experiments, as reported here, are useful for investigating and optimizing follow-up schemes.
              Bookmark
              • Record: found
              • Abstract: not found
              • Book: not found

              Statistical Methods for Forecasting

                Bookmark

                Author and article information

                Journal
                Transl Vis Sci Technol
                Transl Vis Sci Technol
                tvst
                tvst
                TVST
                Translational Vision Science & Technology
                The Association for Research in Vision and Ophthalmology
                2164-2591
                1 May 2017
                May 2017
                : 6
                : 3
                : 1
                Affiliations
                [1 ]Departments of Management Sciences/Statistics & Actuarial Science, University of Iowa, Iowa City, IA, USA
                [2 ]Department of Ophthalmology and Visual Sciences, University of Iowa Hospital and Clinics and Iowa City VA Medical Center, Iowa City, IA, USA
                Author notes
                Correspondence: Johannes Ledolter, Tippie College of Business, S352 Pappajohn Business Building, University of Iowa, Iowa City, IA 52242, USA. e-mail: johannes-ledolter@ 123456uiowa.edu
                Article
                tvst-06-02-14 TVST-16-0432
                10.1167/tvst.6.3.1
                5412967
                28473945
                54054d97-2cd8-49f8-88da-004ddc2b6a40
                Copyright 2017 The Authors

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

                History
                : 11 October 2016
                : 17 March 2017
                Categories
                Articles

                trend change detection,patient monitoring,sampling frequency,autocorrelation,statistical power

                Comments

                Comment on this article